CY1356A - Sustained release lithium-containing tablets and method for their manufacture - Google Patents

Sustained release lithium-containing tablets and method for their manufacture Download PDF

Info

Publication number
CY1356A
CY1356A CY135683A CY135683A CY1356A CY 1356 A CY1356 A CY 1356A CY 135683 A CY135683 A CY 135683A CY 135683 A CY135683 A CY 135683A CY 1356 A CY1356 A CY 1356A
Authority
CY
Cyprus
Prior art keywords
lithium carbonate
particle diameter
sustained release
tablets
mixture
Prior art date
Application number
CY135683A
Other languages
English (en)
Inventor
John Trigger David
Original Assignee
Delandale Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delandale Lab Ltd filed Critical Delandale Lab Ltd
Publication of CY1356A publication Critical patent/CY1356A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY135683A 1982-04-30 1983-04-19 Sustained release lithium-containing tablets and method for their manufacture CY1356A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8212636 1982-04-30

Publications (1)

Publication Number Publication Date
CY1356A true CY1356A (en) 1987-08-07

Family

ID=10530100

Family Applications (1)

Application Number Title Priority Date Filing Date
CY135683A CY1356A (en) 1982-04-30 1983-04-19 Sustained release lithium-containing tablets and method for their manufacture

Country Status (14)

Country Link
EP (1) EP0093538B1 (de)
AT (1) ATE15760T1 (de)
AU (1) AU551212B2 (de)
CA (1) CA1200502A (de)
CY (1) CY1356A (de)
DE (1) DE3360873D1 (de)
EG (1) EG17257A (de)
GB (1) GB2119247B (de)
GR (1) GR78843B (de)
IL (1) IL68482A (de)
MT (1) MTP930B (de)
NZ (1) NZ203959A (de)
PT (1) PT76567B (de)
ZA (1) ZA832799B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8730011D0 (en) * 1987-12-23 1988-02-03 Smithkline Dauelsberg Pharmaceutical compositions
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
GB9018839D0 (en) * 1990-08-29 1990-10-10 Newton John M Slow release compositions
FR2740342B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de manganese, de lithium, d'etain, de zinc ou d'yttrium, de cobalt, de baryum, de strontium dans des compositions pharmaceutiques
GB9806462D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved compositions for inhalation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1209093A (en) * 1968-07-16 1970-10-14 Delandale Lab Ltd Pharmaceutical preparation
GB1450536A (en) * 1972-11-27 1976-09-22 Delandale Lab Ltd Method of making tablets
GB2016922B (en) * 1978-02-17 1982-08-18 Delandale Lab Ltd Sustained release lithium carbonate tables

Also Published As

Publication number Publication date
EP0093538A1 (de) 1983-11-09
ZA832799B (en) 1984-01-25
CA1200502A (en) 1986-02-11
GR78843B (de) 1984-10-02
PT76567B (en) 1985-12-10
PT76567A (en) 1983-05-01
AU1387983A (en) 1983-11-03
DE3360873D1 (en) 1985-10-31
GB2119247B (en) 1985-08-07
NZ203959A (en) 1985-10-11
EG17257A (en) 1991-03-30
MTP930B (en) 1984-04-10
AU551212B2 (en) 1986-04-17
IL68482A (en) 1986-12-31
IL68482A0 (en) 1983-07-31
GB8310535D0 (en) 1983-05-25
GB2119247A (en) 1983-11-16
ATE15760T1 (de) 1985-10-15
EP0093538B1 (de) 1985-09-25

Similar Documents

Publication Publication Date Title
US6399096B1 (en) Pharmaceutical formulation
DE60017363T2 (de) Kontrollierte freisetzung eines verbundmaterials
US3279998A (en) Method of preparing sustained release tablets
CN1071116C (zh) 哌罗克西丁片剂及其制备方法
IE850744L (en) Storage-stable, quick-disintegrating pharmaceuticals
DE2808514A1 (de) Nitrofurantoin enthaltende tablette
JPH11124327A (ja) トラマドール又はその薬剤学上許容される塩の使用方法および鎮痛薬剤
AU4706993A (en) Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof
DE1258548B (de) Verfahren zur Herstellung von Arzneimitteltabletten unter Verwendung von Kunstharzen als die Wirkstoffabgabe verzoegernde Einbettungsmassen
WO1993005769A1 (en) Controlled release pharmaceutical preparations
RU2001110355A (ru) Независящие от влияния пищи фармацевтические дозированные препаративные формы пролонгированного действия, содержащие множество единиц, и способ их получения
DE19820801A1 (de) Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
JPH0759502B2 (ja) 調節放出型剤形用の乾式直接圧縮組成物
EP0093538B1 (de) Lithium enthaltende Tabletten mit verzögerter Wirkstoffabgabe, sowie Verfahren zu deren Herstellung
CA2397942C (en) Controlled release pharmaceutical composition containing tramadol hydrochloride and method for its preparation
Shirwaikar et al. Formulation and evaluation of sustained release tablets using an insoluble rosin matrix system
US3322633A (en) Pharmaceutical preparations
JPH0656700A (ja) 細粒用コーティング核
WO1992004032A1 (en) Slow release compositions
He et al. Formulation development and process scale up of a high shear wet granulation formulation containing a poorly wettable drug
DE2314270A1 (de) Hochwirksame zubereitungsform von fluoresceinestern und verfahren zur herstellung derselben
Yadav et al. Evaluation of seed flour of Vigna mungo (L.) based sustained release matrix tablets of diclofenac sodium
RU20030U1 (ru) Таблетка
JPS61181345A (ja) 釣りのバラケエサとして使用される練りエサ
AU2003240776A1 (en) A method to improve surface properties of pharmaceutical tablets